Zevra Therapeutics, Inc. (ZVRA) Balance Sheet
As of 2026-06-30 (10-Q), Zevra Therapeutics, Inc. (ZVRA) reported total assets of $302.7M, total liabilities of $85.1M and shareholders' equity of $217.7M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $145.3M. Long-term debt: $0.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ZVRAZevra Therapeutics, Inc.Follow ZVRA — free
—
Price chart with a free account
- Market cap
- 582.6M
- P/E TTM
- 10.7
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 32.3 | 16.8 | 10.9 | 18.4 | 3.2 | 4.2 | 112.3 | 65.5 | 43.0 | 33.8 | 62.4 | 145.3 | |
| Short-term investments | 19.0 | 51.0 | 31.4 | 3.3 | — | — | 0.0 | 16.9 | 24.7 | 35.7 | 128.6 | 76.2 | |
| Receivables | — | 5.0 | 2.0 | 0.0 | 1.7 | 2.4 | 1.4 | 8.3 | 17.4 | 10.5 | 23.3 | 22.5 | |
| Inventory | — | — | — | — | — | — | — | 0.7 | 5.0 | 1.8 | 0.8 | 1.7 | |
| Current assets | 54.1 | 74.4 | 45.9 | 23.7 | 7.0 | 8.4 | 115.1 | 92.8 | 86.9 | 86.0 | 223.0 | 251.3 | |
| Total assets | 54.6 | 84.9 | 52.5 | 26.7 | 10.5 | 11.2 | 132.9 | 115.3 | 172.3 | 178.1 | 284.7 | 302.7 | |
| Current liabilities | 8.3 | 6.6 | 11.5 | 12.0 | 5.4 | 7.5 | 4.2 | 12.0 | 73.7 | 34.1 | 39.3 | 48.6 | |
| Long-term debt | — | — | 92.7 | 81.4 | 77.3 | 67.7 | 0.0 | 0.0 | 5.1 | 59.5 | 61.9 | 0.0 | |
| Short-term debt | 1.4 | — | 3.3 | 3.3 | — | — | — | — | — | — | — | — | |
| Total liabilities | 64.7 | 103.6 | 110.0 | 93.3 | 85.0 | 77.6 | 5.8 | 40.2 | 110.5 | 138.5 | 130.1 | 85.1 | |
| Shareholders' equity | -10.1 | -18.7 | -57.5 | -66.6 | -74.5 | -66.4 | 101.7 | 75.1 | 61.9 | 39.7 | 154.7 | 217.7 |
USD millions · SEC XBRL
Zevra Therapeutics, Inc. — questions
- How much cash does Zevra Therapeutics, Inc. have?
- $145.3M in cash and cash equivalents as of 2026-06-30.
- How much debt does Zevra Therapeutics, Inc. have?
- $0 of long-term debt as of 2026-06-30.
- What are Zevra Therapeutics, Inc.'s total assets?
- $302.7M as of 2026-06-30.
- What is Zevra Therapeutics, Inc.'s shareholders' equity?
- $217.7M as of 2026-06-30.
Every figure on this page comes from Zevra Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.